R85.612 Low grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL)

Name of the Condition

• Low grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL)

Summary

A low grade squamous intraepithelial lesion (LGSIL) on a cytologic smear of the anus indicates the presence of mildly abnormal cells detected during a microscopic examination of an anal sample. This finding suggests a precancerous change in the anal epithelium, which may require further evaluation to assess the extent of the abnormality and determine appropriate management.

Causes

The condition arises when cells in the anal squamous epithelium exhibit mild atypical changes, often linked to persistent infection with certain types of human papillomavirus (HPV). Other contributing factors may include chronic inflammation or immune dysregulation, though HPV is the most common etiologic agent.

Risk Factors

• Infection with high-risk human papillomavirus (HPV) types
• Immunosuppression (e.g., HIV infection, organ transplantation)
• History of receptive anal intercourse
• Prior history of anogenital warts or dysplasia
• Smoking
• Age (particularly over 50)

Symptoms

• Often asymptomatic, as the lesion is typically identified through screening.
• Possible symptoms if an underlying condition is present: anal itching, mild bleeding, or discomfort.

Diagnosis

Diagnosis involves an anal cytologic smear (anal Pap test) to detect abnormal cells. Further evaluation may include high-resolution anoscopy (HRA) with biopsy of suspicious areas to confirm the presence and grade of dysplasia.

Treatment Options

Management depends on the extent of the lesion and patient risk factors. Options may include:

• Observation with regular monitoring for low-risk cases.
• Topical treatments (e.g., imiquimod) to target HPV-related changes.
• Surgical excision or ablation for persistent or progressive lesions.

Prognosis and Follow-Up

LGSIL is generally associated with a low risk of progression to cancer. Most lesions regress spontaneously, but regular follow-up with cytologic screening or HRA is recommended to monitor for changes. Follow-up intervals are determined by the severity of the lesion and individual risk factors.

Complications

• Progression to high-grade dysplasia or anal cancer, though this is uncommon.
• Persistent symptoms such as itching or bleeding if the lesion is untreated.
• Psychological distress related to abnormal test results.

Lifestyle & Prevention

• HPV vaccination to reduce infection risk.
• Safe sexual practices, including consistent condom use.
• Smoking cessation to lower immunosuppressive effects.
• Regular anal cytology screening for high-risk individuals.

When to Seek Professional Help

Seek medical evaluation if you experience persistent anal symptoms (e.g., bleeding, pain, itching) or have risk factors for HPV-related dysplasia. Prompt assessment is recommended for abnormal screening results to guide timely management.

Tips for Medical Coders

• Code R85.612 is specific to low grade squamous intraepithelial lesions identified on cytologic smears of the anus. Ensure documentation supports the grade (low) and site (anus) to justify this code.
• Differentiate from high-grade lesions (e.g., HSIL) or unspecified abnormalities, as coding accuracy depends on precise clinical documentation.
• Verify that the cytologic smear was performed on an anal specimen, as the code is site-specific.